Condition: Overactive Bladder (OAB) · Urinary Urgency · Urinary Urge Incontinence (UUI) · Sponsor: Medstar Health Research Institute
The APPROVE trial is a multi-centered, randomized controlled trial designed to assess differences in symptom improvement, quality of life, bladder symptoms, satisfaction with treatment and continued treatment efficacy in women with overactive bladder (OAB) randomized to a prescription digital therapeutic (PDTx) app called RiSolve compared to standard behavioral education (handouts).
This description comes directly from the study's public registry record.
Patricia Moriarty · 202-877-0486 · approvetrial@medstar.net
Alexis Dieter, MD · 202-877-6526
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Stanford University | Palo Alto, California, United States | Recruiting |
| MedStar Health | Washington D.C., District of Columbia, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Recruiting |
| Curavit | Boston, Massachusetts, United States | Active Not Recruiting |
| Atrium Health Wake Forest Baptist | Winston-Salem, North Carolina, United States | Recruiting |
| Allegheny Health | Pittsburgh, Pennsylvania, United States | Recruiting |
| Medical University of South Carolina Health | Charleston, South Carolina, United States | Recruiting |
| UT Southwestern Medical Center | Dallas, Texas, United States | Recruiting |
| University of Wisconsin | Madison, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06797245